The Relentless Rise of Healthcare Expenditures
Need I say more?
Similar Posts
Are Rare Diseases Too Expensive to Treat?
ByadminSee this great piece by a reporter at Forbes discussing why rare disease treatments can cost as much as $400,000 per patient, per year. You will get a glimpse of my take on this topic too, but I plan on writing more about it in the future.
Why You Should Know the Cost of Your Medical Treatments
ByadminCheck out this WHYY Radio Times segment I participated in on health care price transparency: When it comes to the cost of treating an illness, do you know how much your care costs? Many experts believe if patients would be more value- and cost-conscious when it comes to choosing where they receive care, overall health…
Turmoil in the Obamacare Exchanges
ByadminHere is a nice story from a NC news station explaining the turmoil in the exchanges, with Aetna pulling out of many markets. Worth a quick read. North Carolina consumers buying broadly subsidized health insurance policies on the online marketplace created by the Affordable Care Act will have fewer options after a major insurer pulls…
Proven: People Don't Take Medicine They Can't Afford
ByadminCholesterol pills are one of the great medical advances I’ve witnessed during my professional career. I am talking specifically about a category of medications called statins, drugs like Lipitor and Pravachol. These drugs have prevented probably hundreds of thousands of heart attacks and strokes. Only one problem with these drugs, however: statins won’t help people…
Something I Have in Common with Beethoven
ByadminFriends and family are painfully aware of how obsessed I have become with Beethoven lately. My plan is to have 10 of his piano sonatas in my brain and fingertips at any one time, ready to play by memory on demand. I’ve been listening to his music, studying his scores, and even reading biographies. And…
Why Are Investors Running Away from Medical Devices?
ByadminSabin Russell wrote a great piece in Health Affairs recently, on the drought in investment to develop new medical devices. Read it if you have access. If you don’t, here are some of her main points. 1. Venture capital for device manufacturers has been drying up for a while: “‘For five years, this industry has…